Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Emtriva Emtricitabine 200mg Capsule Gilead Sciences (NZ) Abbott Laboratories Inc, Illinois, United States of America Excella GmbH, Feucht, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Synacthen Tetracosactide 0.25mg/mL equivalent to Tetracosactide hexaacetate 0.28mg/mL Solution for injection Novartis New Zealand Limited Takeda Austria GmbH, Linz, Austria
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Synacthen Depot Tetracosactide 1mg/mL equivalent to Tetracosactide hexaacetate 1.12mg/mL Injection (depot) Novartis New Zealand Limited Takeda Austria GmbH, Linz, Austria
|
Dated this 3rd day of December 2014.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).